Order Article Reprints

Yokoyama K, Fukuda H, Yamauchi R, Higashi M, Miyayama T, Higashi T, Uchida Y, Shibata K, Tsuchiya N, Fukunaga A, et al. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina. 2022; 58(9):1276. https://doi.org/10.3390/medicina58091276

Yokoyama, Keiji, Hiromi Fukuda, Ryo Yamauchi, Masashi Higashi, Takashi Miyayama, Tomotaka Higashi, Yotaro Uchida, Kumiko Shibata, Naoaki Tsuchiya, Atsushi Fukunaga, and et al. 2022. "Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites" Medicina 58, no. 9: 1276. https://doi.org/10.3390/medicina58091276

Yokoyama, K., Fukuda, H., Yamauchi, R., Higashi, M., Miyayama, T., Higashi, T., Uchida, Y., Shibata, K., Tsuchiya, N., Fukunaga, A., Umeda, K., Takata, K., Tanaka, T., Shakado, S., Sakisaka, S., & Hirai, F. (2022). Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina, 58(9), 1276. https://doi.org/10.3390/medicina58091276